HUMAN EMBRYONIC STEM CELLS MARKET ANALYSIS
Global Human Embryonic Stem Cells Market: Key Developments
In July 2020, Thermo Fisher Scientific Inc. and QIAGEN N.V. entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.
In January 2020, Astellas Pharma Inc. and Adaptimmune Therapeutics Plc. entered into a co-development and co-commercialization agreement to bring new stem-cell derived allogeneic T-cell therapies to people with cancer.
Global Human Embryonic Stem Cells Market: Key Companies Insights
The global human embryonic stem cells market is highly competitive. This is attributed to the increase in prevalence of cardiac and malignant diseases, as a result, players in the market are focusing on launching novel products in the market.
Some of the key players in the global human embryonic stem cells market are Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, Merck KgaA, PeproTech Inc., Astellas Pharma Inc., Thermo Fisher Scientific, Lineage Cell Therapeutics Inc., and STEMCELL Technologies Inc., among others.
Human Embryonic Stem Cells Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :